Recombinant multi-species CEBP Alpha/CEBPA protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CEBP Alpha/CEBPA protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This intronless gene encodes a transcription factor that contains a basic leucine zipper (bZIP) domain and recognizes the CCAAT motif in the promoters of target genes. The encoded protein functions in homodimers and also heterodimers with CCAAT/enhancer-binding proteins beta and gamma. Activity of this protein can modulate the expression of genes involved in cell cycle regulation as well as in body weight homeostasis. Mutation of this gene is associated with acute myeloid leukemia. The use of alternative in-frame non-AUG (GUG) and AUG start codons results in protein isoforms with different lengths. Differential translation initiation is mediated by an out-of-frame, upstream open reading frame which is located between the GUG and the first AUG start codons. [provided by RefSeq, Dec 2013]
The Alternative Names of target: C/EBP alpha,C/EBP-alpha,C/ebpalpha,CBF-A,CCAAT/enhancer-binding protein alpha,CEBP,CEBP Alpha,CEBPA,Cebp,Cebpa,DBPCEP

Target products collectionGo to CEBP Alpha/CEBPA products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP3551-Ag-1/ GM-Tg-hg-IP3551-Ag-2 Human CEBP Alpha/CEBPA protein Human
GM-Tg-rg-IP3551-Ag-1/ GM-Tg-rg-IP3551-Ag-2 Rat CEBP Alpha/CEBPA protein Rat
GM-Tg-mg-IP3551-Ag-1/ GM-Tg-mg-IP3551-Ag-2 Mouse CEBP Alpha/CEBPA protein Mouse
GM-Tg-cynog-IP3551-Ag-1/ GM-Tg-cynog-IP3551-Ag-2 Cynomolgus/Rhesus macaque CEBP Alpha/CEBPA protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP3551-Ag-1/ GM-Tg-felg-IP3551-Ag-2 Feline CEBP Alpha/CEBPA protein Feline
GM-Tg-cang-IP3551-Ag-1/ GM-Tg-cang-IP3551-Ag-2 Canine CEBP Alpha/CEBPA protein Canine
GM-Tg-bovg-IP3551-Ag-1/ GM-Tg-bovg-IP3551-Ag-2 Bovine CEBP Alpha/CEBPA protein Bovine
GM-Tg-equg-IP3551-Ag-1/ GM-Tg-equg-IP3551-Ag-2 Equine CEBP Alpha/CEBPA protein Equine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP3551-Ag-1/ GM-Tg-hg-IP3551-Ag-2; GM-Tg-rg-IP3551-Ag-1/ GM-Tg-rg-IP3551-Ag-2;
GM-Tg-mg-IP3551-Ag-1/ GM-Tg-mg-IP3551-Ag-2; GM-Tg-cynog-IP3551-Ag-1/ GM-Tg-cynog-IP3551-Ag-2;
GM-Tg-felg-IP3551-Ag-1/ GM-Tg-felg-IP3551-Ag-2; GM-Tg-cang-IP3551-Ag-1/ GM-Tg-cang-IP3551-Ag-2;
GM-Tg-bovg-IP3551-Ag-1/ GM-Tg-bovg-IP3551-Ag-2; GM-Tg-equg-IP3551-Ag-1/ GM-Tg-equg-IP3551-Ag-2
Products Name CEBP Alpha/CEBPA protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name CEBP Alpha/CEBPA
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CEBP Alpha/CEBPA protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.